Beyond Chemoradiotherapy: Improving Treatment Outcomes Or Patients With Stage Iii Nresectable Non-Small-Cell Lung Cancer Through Immuno-Oncology And Durvalumab (Imfinzi (R) Down-Pointingtriangle, Astrazeneca Uk Limited)